GLP-1在不一样组织结构中存在多重影响和大范围的方法空间。GLP-1 shows numerous actions in different tissues, and a broad therapeutic potential.GLP-1的大部分反应是激励胰岛素分泌量出并压制胰高血糖素分泌量出,最终得以有助于、把控好餐后血糖波动性。The main actions of GLP-1 are to stimulate insulin secretion and to inhibit glucagon secretion,thereby contributing to limit postprandial glucose excursions.GLP-1 需要加强饱腹感而引起增重消除,不仅,GLP-1还遏制肠腔道运动健身和代谢分泌,需要代替胃素和“回肠制动器”共识机制的一本分。GLP-1 also causes weight loss by increasing satiety. In addition, GLP-1 also inhibits gastrointestinal motility and secretion,and thus acts as an enterogastrone and part of the "ileal brake" mechanism.